Kamal Fariborz (CIK 0001834020)

Latest company ownership

Shares held
260,000
Last filed at
Dec 13, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 15, 2020 Dec 17, 2020 4D Molecular Therapeutics, Inc. Officer Buy 95.0 +4,347 100.00% ✗ $100K